Skip to main content

Table 2 Plasma fatty acid profiles (% of total fatty acids) from rats fed experimental diets for 2 or 6 months.

From: Effects of alpha-linolenic acid vs. docosahexaenoic acid supply on the distribution of fatty acids among the rat cardiac subcellular membranes after a short- or long-term dietary exposure

Duration (months)

2

2

2

6

6

6

 

Dietary groups

CTL

DHA

ALA

CTL

DHA

ALA

 

Fatty acids:

      

CI

14:0

0.6 ± 0.6

0.2 ± 0.1

0.2 ± 0.0

1.0 ± 0.2

1.0 ± 0.2***

0.8 ± 0.1

-

16:0

14.6 ± 1.3b

17.3 ± 1.4a

17.6 ± 0.8a

20.0 ± 0.8b ***

24.2 ± 0.8a ***

22.3 ± 0.8a ***

-

16:1 n-9

0.2 ± 0.1

0.2 ± 0.0

0.2 ± 0.0

0.3 ± 0.0

0.3 ± 0.1***

0.4 ± 0.0

-

16:1 n-7

1.7 ± 0.1

2.0 ± 0.6

2.2 ± 0.4

2.4 ± 0.8

2.7 ± 0.7

2.4 ± 0.8

-

18:0

12.1 ± 1.0b

12.2 ± 0.5b

13.7 ± 1.0a

12.3 ± 0.9b

13.2 ± 1.0b

14.5 ± 0.8a

-

18:1 n-9

15.4 ± 0.9

16.8 ± 0.9

15.5 ± 1.0

15.4 ± 1.2*

14.9 ± 2.1*

13.9 ± 0.5*

-

18:1 n-7

2.1 ± 0.2

1.8 ± 0.1

1.9 ± 0.2

2.2 ± 0.4a

1.7 ± 0.2b

1.6 ± 0.1b

-

18:2 n-6

27.3 ± 1.4a

19.3 ± 1.4b

20.3 ± 1.0b

25.5 ± 1.3a *

19.0 ± 0.9b

18.7 ± 0.9b

-

18:3 n-6

0.4 ± 0.1a

0.3 ± 0.1a

<0.1b

0.5 ± 0.1a

<0.1c

0.2 ± 0.1b

-

18:3 n-3

0.3 ± 0.0b

0.7 ± 0.1b

8.4 ± 0.9a

0.3 ± 0.0b

0.7 ± 0.1b

8.1 ± 0.4a

-

20:3 n-6

0.5 ± 0.1b

0.4 ± 0.1b

0.7 ± 0.2a

0.5 ± 0.1a

0.4 ± 0.1b

0.6 ± 0.1a

-

20:4 n-6

21.3 ± 0.6a

7.4 ± 0.9b

7.5 ± 0.6b

16.7 ± 1.7a ***

6.7 ± 1.0b

6.7 ± 0.5b

-

20:5 n-3

<0.1b

5.7 ± 0.8a

5.6 ± 0.8a

<0.1c

3.4 ± 0.4b ***

4.8 ± 0.3a ***

$

22:4 n-6

0.5 ± 0.1a

<0.1b

<0.1b

0.4 ± 0.1a

<0.1b

<0.1b

-

22:5 n-6

0.5 ± 0.1a

0.5 ± 0.0a

<0.1b

0.4 ± 0.1a

0.1 ± 0.01a

<0.1b

-

22:5 n-3

0.1 ± 0.0c

1.0 ± 0.2b

1.8 ± 0.2a

<0.1c

0.6 ± 0.1b ***

1.4 ± 0.2a ***

$

22:6 n-3

0.8 ± 0.1c

12.6 ± 0.7a

2.8 ± 0.4b

0.6 ± 0.1c

9.3 ± 0.4a ***

2.2 ± 0.3b

$

SFA

27.8 ± 1.7b

30.3 ± 1.4a

32.0 ± 1.0a

33.8 ± 0.5b ***

38.9 ± 1.4a ***

38.1 ± 0.6a ***

-

MUFA

19.9 ± 1.1

21.2 ± 1.6

20.2 ± 1.5

20.7 ± 2.1

19.9 ± 2.2

18.6 ± 0.8

-

PUFA

52.2 ± 0.7a

48.5 ± 2.6b

47.8 ± 1.1b

45.5 ± 2.1a ***

41.2 ± 1.8b ***

43.3 ± 0.6b ***

-

n-6 PUFA

50.8 ± 0.8a

28.4 ± 2.1b

28.8 ± 1.6b

44.3 ± 2.0a ***

27.2 ± 1.6b

26.4 ± 0.9b

$

n-3 PUFA

1.3 ± 0.1b

20.1 ± 1.5a

18.9 ± 1.1a

1.1 ± 0.1b

14.0 ± 0.6a ***

16.8 ± 0.7a ***

$

n-6/n-3 ratio

37.9 ± 2.8a

1.4 ± 0.2b

1.5 ± 0.2b

40.1 ± 1.2a *

1.9 ± 0.1b *

1.6 ± 0.1b *

-

P/S ratio

1.9 ± 0.1a

1.6 ± 0.2b

1.5 ± 0.1b

1.3 ± 0.1a ***

1.1 ± 0.1b ***

1.1 ± 0.0b ***

-

[plasma FA] (μg/mL)

803 ± 6.8a

427 ± 49.7b

590 ± 35.2b

858 ± 14.4a *

441 ± 67.2b

519 ± 32.4b

$

  1. SFA. MUFA. and PUFA. saturated. monounsaturated. and polyunsaturated FA; CTL. n-3 PUFA free diet; DHA. docosahexaenoic acid-rich diet; ALA. alpha linolenic acid-rich diet.
  2. Data are means ± SEM. n = 4. Dietary effect (CTL versus DHA versus ALA) was compared in rats from the same dietary treatment duration and values with different letters are statistically different. a>b>c. p < 0.01. Time effect (2 months versus 6 months) was compared between rats from the same dietary group. with * = p < 0.05; ** = p < 0.01. *** = p < 0.001). Symbol $ denoted significant cross-interaction. p < 0.05.